Last update :
03/05/2024
Diuretic   Furosemide  
Injection
Oral solution
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Asadiur Mexico
Demistec Mexico
Desal Turkey
Diorin Colombia
Diural Denmark, Norway
Diurapid Germany
Diurefur Peru
Diuresal Switzerland
Edemid Croatia, Slovenia, Venezuela
Edenol Mexico
Frusemide Australia, Ireland, New Zealand
Frusix Venezuela
Furesis Finland
Furilan Morocco, Tunisia
Furital Argentina
Furix Denmark, Iceland, Norway, Sweden
Furodiurol Mexico
Furohexal Austria
Furomid Turkey
Furon Austria, Hungary
Furophax Peru
Furorese Germany, Luxembourg
Furosan Mexico
Furoxem Tunisia
Fursemid Germany
Hydroflux Greece
Impugan Sweden
Kolkin Argentina
Lasilix France, Hungary, Japan, Morocco, Poland, Tunisia, United States of America
Lasiphar Egypt
Lasix Argentina, Australia, Austria, Belgium, Brazil, Chile, Colombia, Egypt, Germany, Great Britain, Greece, Italy, Luxembourg, Mexico, Netherlands, New Zealand, Portugal, Republic of South Africa, Saudi Arabia, Switzerland, Turkey
Nacua Venezuela
Oedemex Switzerland
Salex Egypt
Salurin Saudi Arabia, United Arab Emirates
Seguril Spain
Uradex Turkey
Urever Turkey
Stability of mixtures   Injection   Stability of mixtures : Furosemide     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 0,5 & 10 mg/ml
Injection   Furosemide   
Injection   Tirofiban 50 µg/ml
20°C-25°C
4 Hour
Light 1603
Level of evidence A+
Glass Sodium chloride 0,9% 0,2 mg/ml
Injection   Furosemide   
Injection   Granisetron hydrochloride 0,5 mg/ml
20°C-23°C
4 Hour
Protect from light 57
Level of evidence A+
Glass None 1.07 mg/ml
Injection   Furosemide   
Injection   Human albumin 250 mg/ml
25°C
48 Hour
Protect from light 3490
Level of evidence C
Glass None 1.07 mg/ml
Injection   Furosemide   
Injection   Human albumin 250 mg/ml
4°C
14 Day
Protect from light 3490
Level of evidence C
Polypropylene Sodium chloride 0,9% 3.33>>10 mg/ml
Injection   Furosemide   
Injection   Dexamethasone sodium phosphate 0.33>>3.33 mg/ml
25°C
5 Day
Protect from light 2205
Level of evidence C
Polypropylene Sodium chloride 0,9% 3.33>>10 mg/ml
Injection   Furosemide   
Injection   Dexamethasone sodium phosphate 0.33>>3.33 mg/ml
5°C
5 Day
Protect from light 2205
Level of evidence C
Polypropylen Syringe Glucose 5% 1 mg/ml
Injection   Furosemide   
Injection   Chlorothiazide sodium 10 mg/ml
25°C
96 Hour
Protect from light 3821
Level of evidence D
Not specified Glucose 5% 0,2 mg/ml
Injection   Furosemide   
Injection   Cefoperazone sodium 10 mg/ml
25°C
2 Day
Protect from light 87
Level of evidence A
Not specified Glucose 5% 0,2 mg/ml
Injection   Furosemide   
Injection   Cefoperazone sodium 10 mg/ml
4°C
5 Day
Protect from light 87
Level of evidence A

  Mentions Légales